ESTA vs. NVST, NVCR, IRTC, LIVN, ENOV, WRBY, TNDM, CNMD, TMDX, and LMAT
Should you be buying Establishment Labs stock or one of its competitors? The main competitors of Establishment Labs include Envista (NVST), NovoCure (NVCR), iRhythm Technologies (IRTC), LivaNova (LIVN), Enovis (ENOV), Warby Parker (WRBY), Tandem Diabetes Care (TNDM), CONMED (CNMD), TransMedics Group (TMDX), and LeMaitre Vascular (LMAT). These companies are all part of the "medical equipment" industry.
Establishment Labs vs.
Envista (NYSE:NVST) and Establishment Labs (NASDAQ:ESTA) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, institutional ownership, media sentiment, community ranking, earnings, dividends, analyst recommendations, valuation and profitability.
Establishment Labs received 83 more outperform votes than Envista when rated by MarketBeat users. Likewise, 61.90% of users gave Establishment Labs an outperform vote while only 37.78% of users gave Envista an outperform vote.
Envista currently has a consensus target price of $20.21, suggesting a potential downside of 1.55%. Establishment Labs has a consensus target price of $60.60, suggesting a potential upside of 70.42%. Given Establishment Labs' stronger consensus rating and higher probable upside, analysts clearly believe Establishment Labs is more favorable than Envista.
Establishment Labs has a net margin of -46.13% compared to Envista's net margin of -53.42%. Envista's return on equity of 3.76% beat Establishment Labs' return on equity.
72.9% of Establishment Labs shares are held by institutional investors. 1.3% of Envista shares are held by company insiders. Comparatively, 11.4% of Establishment Labs shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
In the previous week, Establishment Labs had 2 more articles in the media than Envista. MarketBeat recorded 4 mentions for Establishment Labs and 2 mentions for Envista. Establishment Labs' average media sentiment score of 0.56 beat Envista's score of 0.20 indicating that Establishment Labs is being referred to more favorably in the news media.
Establishment Labs has lower revenue, but higher earnings than Envista. Establishment Labs is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks.
Envista has a beta of 1.33, suggesting that its stock price is 33% more volatile than the S&P 500. Comparatively, Establishment Labs has a beta of 1.15, suggesting that its stock price is 15% more volatile than the S&P 500.
Summary
Establishment Labs beats Envista on 13 of the 18 factors compared between the two stocks.
Get Establishment Labs News Delivered to You Automatically
Sign up to receive the latest news and ratings for ESTA and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Establishment Labs Competitors List
Related Companies and Tools
This page (NASDAQ:ESTA) was last updated on 1/22/2025 by MarketBeat.com Staff
